<DOC>
	<DOCNO>NCT02286531</DOCNO>
	<brief_summary>Determine overall discriminatory ability FET PET diagnosis glioma grade II ( refer current diagnostic gold standard represent histopathology exam tumor sample ) .</brief_summary>
	<brief_title>Evaluation de O- ( 2-18F-Fluoroethyl ) -L-Tyrosine , New Tracer PET , Diagnosis Low Grade Glioma</brief_title>
	<detailed_description>Low-grade glioma malignant tumor young adult ( 12.5 % glioma , incidence 0.99 / 100,000 ) . Median survival , link anaplastic transformation estimate 7 10 year , great individual variability rate evolution . The morphological MRI , standard assessment tool present , suffers many limitation , especially concern positive diagnosis , target surgical biopsy tumor delineation essential treatment The study design validation study new diagnostic procedure . This study prospective , randomize , multicenter involve 10 center ( Toulouse University Hospital , Caen , Tours , AP-HP Pitie Salpetriere , Lille , Angers , Rennes , NÃ®mes , Nantes Nancy ) . Will eligible patient diagnosis grade II glioma suspect accord clinical data MRI , evaluation multidisciplinary meeting histological confirmation schedule within maximum period one month . FET PET scan perform procedure surgical treatment data merge MRI . The gold standard histological examination biopsy material , complete resection tumor . A minimum three biopsy per patient realize . The pathologist see result PET-FET 100 patient enrolled period 5 year . The area curve determine non-parametric increase value PET-FET near 10th . The sensitivity , specificity , positive predictive value estimate confidence interval 95 % . Factors consider analysis , intrasubject variability relate fact several positive negative result find subject include . The concordance data-FET PET MRI seek . The expected benefit well diagnostic ability PET-FET result specific target biopsy few test false negative false positive , thus well diagnostic yield invasive procedure . Furthermore , characteristic test apply tumor may help good define limit healthy tumor area thus reduce radiation field volume strictly necessary . These volume currently define result morphological MRI clarify</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Patients 18 year Diagnosis glioma grade II refer clinical MRI morphologic Realization brain MRI preoperative condition neuronavigation ( MRI sequence include axial T2 , Flair , T1 , T1 gadolinium ) within 1 month FET PET . Histological examination schedule within one month FET PET resection ( complete partial ) biopsy Patients sign informed consent No againstindication PET No againstindications MRI Grade II glioma receive specific treatment radiotherapy chemotherapy . Pregnant breastfeed woman . Weight great 120 Kg againstindication PET indication gadolinium Possible side effect MRI ( magnetic foreign body , pacemaker , congestive severe renal ) . ) Patient guardianship No coverage social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>: Low grade glioma</keyword>
	<keyword>PET</keyword>
	<keyword>FET</keyword>
	<keyword>MRI</keyword>
	<keyword>Standardized uptake value</keyword>
</DOC>